TNF and arthropathy: Given previous work suggesting the higher efficacy of anti-TNFα compared to anti-IL12/23 therapy for SpA symptoms,28 further work is needed to define the potential medication-specific impact and to assess longitudinal tracking of specific strains associated with joint disease activity.